Cargando…

Multiparametric (18)F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

SIMPLE SUMMARY: In breast cancer, the leading cancer type and the main cause of cancer death in women, achieving pathological complete response after neoadjuvant chemotherapy has been shown to be associated with prolonged overall survival. Hence, the correct assessment and the potential prediction o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umutlu, Lale, Kirchner, Julian, Bruckmann, Nils-Martin, Morawitz, Janna, Antoch, Gerald, Ting, Saskia, Bittner, Ann-Kathrin, Hoffmann, Oliver, Häberle, Lena, Ruckhäberle, Eugen, Catalano, Onofrio Antonio, Chodyla, Michal, Grueneisen, Johannes, Quick, Harald H., Fendler, Wolfgang P., Rischpler, Christoph, Herrmann, Ken, Gibbs, Peter, Pinker, Katja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996836/ https://www.ncbi.nlm.nih.gov/pubmed/35406499 http://dx.doi.org/10.3390/cancers14071727

Ejemplares similares

Multiparametric Integrated (18)F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding
por: Umutlu, Lale, et al.
Publicado: (2021)

Conventional Imaging, MRI and (18)F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer
por: Morawitz, Janna, et al.
Publicado: (2023)

Comparison of nodal staging between CT, MRI, and [(18)F]-FDG PET/MRI in patients with newly diagnosed breast cancer
por: Morawitz, Janna, et al.
Publicado: (2021)

Evaluation of the Predictive Potential of 18F-FDG PET and DWI Data Sets for Relevant Prognostic Parameters of Primary Soft-Tissue Sarcomas
por: Chodyla, Michal, et al.
Publicado: (2021)

Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI—Clinically Relevant?
por: Jannusch, Kai, et al.
Publicado: (2022)

[(18)F]FDG PET/MRI in children suffering from lymphoma: does MRI contrast media make a difference?
por: Jannusch, Kai, et al.
Publicado: (2023)

Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in (18)F-FDG PET/MRI
por: Bruckmann, Nils Martin, et al.
Publicado: (2022)

Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer
por: Jannusch, Kai, et al.
Publicado: (2023)

Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times
por: Jannusch, Kai, et al.
Publicado: (2023)

Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma: Preliminary Results
por: Chodyla, Michal, et al.
Publicado: (2022)

Prospective comparison of CT and (18)F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results
por: Bruckmann, Nils Martin, et al.
Publicado: (2021)

Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from (68)Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
por: Weber, Manuel, et al.
Publicado: (2020)

A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer
por: Demircioglu, Aydin, et al.
Publicado: (2020)

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast (18)F-FDG PET/MRI compared to (18)F-FDG PET/CT and CT
por: Kirchner, Julian, et al.
Publicado: (2017)

Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients
por: Bruckmann, Nils Martin, et al.
Publicado: (2021)

Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer
por: Kersting, David, et al.
Publicado: (2021)

Prospective evaluation of whole-body MRI and (18)F-FDG PET/MRI in N and M staging of primary breast cancer patients
por: Bruckmann, Nils Martin, et al.
Publicado: (2020)

Update on Locoregional Therapies for Cholangiocellular Carcinoma
por: Morawitz, Janna, et al.
Publicado: (2023)

Just another “Clever Hans”? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
por: Weber, Manuel, et al.
Publicado: (2021)

(18)F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET?
por: Li, Yan, et al.
Publicado: (2020)

Radiomics and Machine Learning with Multiparametric Breast MRI for Improved Diagnostic Accuracy in Breast Cancer Diagnosis
por: Daimiel Naranjo, Isaac, et al.
Publicado: (2021)

A Simultaneous Multiparametric (18)F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer
por: Romeo, Valeria, et al.
Publicado: (2022)

Breast Lesion Classification with Multiparametric Breast MRI Using Radiomics and Machine Learning: A Comparison with Radiologists’ Performance
por: Daimiel Naranjo, Isaac, et al.
Publicado: (2022)

Evaluation of (18)F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision
por: Weber, Manuel, et al.
Publicado: (2021)

Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancer
por: Kersting, David, et al.
Publicado: (2021)

Intra-Individual Comparison of (124)I-PET/CT and (124)I-PET/MR Hybrid Imaging of Patients with Resected Differentiated Thyroid Carcinoma: Aspects of Attenuation Correction
por: Grafe, Hong, et al.
Publicado: (2022)

Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body (68) Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer after radical prostatectomy?
por: Morawitz, Janna, et al.
Publicado: (2022)

Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics
por: Leithner, Doris, et al.
Publicado: (2020)

Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124
por: Kersting, David, et al.
Publicado: (2021)

Towards fast whole-body PET/MR: Investigation of PET image quality versus reduced PET acquisition times
por: Lindemann, Maike E., et al.
Publicado: (2018)

First experiences with dynamic renal [(68)Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate
por: Kersting, David, et al.
Publicado: (2022)

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [(18)F]FDG PET/CT compared to the histopathology reference standard
por: Hautzel, Hubertus, et al.
Publicado: (2021)

Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI
por: Grueneisen, Johannes, et al.
Publicado: (2016)

Repeatability of Multiparametric Prostate MRI Radiomics Features
por: Schwier, Michael, et al.
Publicado: (2019)

Diagnostic Performance of Simultaneous [(18)F]-FDG PET/MR for Assessing Endoscopically Active Inflammation in Patients with Ulcerative Colitis: A Prospective Study
por: Langhorst, Jost, et al.
Publicado: (2020)

(18)F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis
por: Deuschl, Cornelius, et al.
Publicado: (2020)

(18)F-flutemetamol positron emission tomography in cardiac amyloidosis
por: Papathanasiou, Maria, et al.
Publicado: (2020)

Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system
por: Fragoso Costa, Pedro, et al.
Publicado: (2022)

[(68)Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas
por: Guberina, Nika, et al.
Publicado: (2022)

Combining the strengths of radiologists and AI for breast cancer screening: a retrospective analysis
por: Leibig, Christian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_to35b98tj8i9om3ivr0e2qf3da